Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial

Summary

The purpose of this study is to test whether treatment with Aripiprazole leads to a reduction in methamphetamine craving and use in patients diagnosed with methamphetamine dependence. Patients presenting at the Omaha VA Medical Center for treatment of methamphetamine dependence, and meet inclusion criteria for the study will be invited to participate. Participation in the study will last for approximately 14 weeks.

Timeline

Start

2009-08

Primary completion

2010-04

Completion

2010-04

Drugs

Indications